Loss of Cdx2 Is a Potential Marker of the Serrated Pathway of Colorectal Cancer Characterized by BRAF Mutation, High-Level CpG Island Methylator Phenotype and Mismatch Repair-Deficiency

Dawson, Heather; Kölzer, Viktor; Karamitopoulou, Evanthia; Lugli, Alessandro; Zlobec, Inti (February 2014). Loss of Cdx2 Is a Potential Marker of the Serrated Pathway of Colorectal Cancer Characterized by BRAF Mutation, High-Level CpG Island Methylator Phenotype and Mismatch Repair-Deficiency. Laboratory investigation, 94, 171A-171A. Nature Publishing Group

Item Type:

Conference or Workshop Item (Abstract)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Pathology > Clinical Pathology
04 Faculty of Medicine > Service Sector > Institute of Pathology

UniBE Contributor:

Dawson, Heather; Kölzer, Viktor; Karamitopoulou, Evanthia; Lugli, Alessandro and Zlobec, Inti

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

0023-6837

Publisher:

Nature Publishing Group

Language:

English

Submitter:

Andrea Arnold

Date Deposited:

25 Sep 2014 11:00

Last Modified:

26 Apr 2017 02:28

Additional Information:

LABORATORY INVESTIGATION Volume: 94 Pages: 171A-171A Supplement: 1 Meeting Abstract: 697 Sponsor(s):US & Canadian Acad Pathol; Dako; Biocare Med; Leica Biosystems; LabCorp Specialty Testing Grp, Integrated Oncol; GenomOncology; Nephropath; Ventana; Diagnost BioSystems

URI:

https://boris.unibe.ch/id/eprint/54031

Actions (login required)

Edit item Edit item
Provide Feedback